Primary research  

Arsenic, cadmium and neuron specific enolase (ENO2, γ-enolase) expression in breast cancer

Maureen A Soh, Scott H Garrett, Seema Somji, Jane R Dunlevy, Xu Zhou, Mary Sens, Chandra S Bathula, Christina Allen, Donald A Sens Cancer Cell International 2011, 11:41 (18 November 2011)

Abstract | Full text | PDF | PubMed

Research article  

Jab1 is a target of EGFR signaling in ERα-negative breast cancer

Jiaxu Wang, Rebecca O Barnes, Nathan R West, Melanie Olson, Jenny E Chu, Peter H Watson Breast Cancer Research 2008, 10:R51 (6 June 2008)

Abstract | Full text | PDF | PubMed

Research  

Meta-analysis of human cancer microarrays reveals GATA3 is integral to the estrogen receptor alpha pathway

Brian J Wilson, Vincent Giguère Molecular Cancer 2008, 7:49 (4 June 2008)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Research article  

An integrated analysis of genes and pathways exhibiting metabolic differences between estrogen receptor positive breast cancer cells

Soma Mandal, James R Davie BMC Cancer 2007, 7:181 (20 September 2007)

Abstract | Full text | PDF | PubMed

Research article  

GATA3 protein as a MUC1 transcriptional regulator in breast cancer cells

Martín C Abba, María I Nunez, Andrea G Colussi, María V Croce, Amada Segal-Eiras, C Marcelo Aldaz Breast Cancer Research 2006, 8:R64 (1 November 2006)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Review  

High-throughput genomic technology in research and clinical management of breast cancer. Exploiting the potential of gene expression profiling: is it ready for the clinic?

Andrew H Sims, Kai Ong, Robert B Clarke, Anthony Howell Breast Cancer Research 2006, 8:214 (11 October 2006)

This article is part of a collection on High-throughput genomic...

Abstract | Full text | PDF | PubMed | Cited on BioMed Central